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To identify the antigen-specific recognition complex containing elements from T cells and 
antigen-presenting cells (APC), a photoactivatable antigen system was developed which could 
potentially crosslink the complex during the specific cellular responses. In this paper we describe 
the development of this system using murine T-cell hybridomas responding to stimulator cells 
chemically conjugated with N-hydroxysuccinimidyl Cazidobenzoate (HSAB) and genetically re- 
stricted by I-Ad. In initial experiments it was found that several I-Ad-positive B-cell lines were 
nonstimulatory when coupled with HSAB, but that I-Ad-positive P388Di macrophage-like cells 
were efficient stimulators of HSAB-specific T-cell responses. These results suggested that the relevant 
HSAB coupled surface structure was not likely I-Ad. To substantiate this point, Ia-positive or Ia- 
negative P388Di cells were initially coupled with HSAB and the expression of Ia was modulated 
by the addition and withdrawal of Con A-stimulated spleen cell supematant fluid through several 
days of culture. Under these conditions, efficient stimulation was only observed when Ia was 
expressed, although the HSAB antigen was continuously present. In other experiments it was 
found that exposure of HSAB-coupled APC to light selectively eliminated their stimulatory capacity 
for HSAB-specific T hybridomas, suggesting that the light-induced crosslinking by HSAB directly 
eliminates the antigenic determinant. This antigen system allows a unique opportunity to ma- 
nipulate the antigen during specific cellular interactions, and to introduce covalent crosslinking 
of the specific antigen recognition complex that may allow its isolation and characterization. 
0 1985 Academic Press. Inc. 
INTRODUCTION 
It was initially thought that macrophages were unique in their ability to stimulate 
specific T-cell responses. This was in part due to their ability to process and present 
antigens and to produce several costimulator factors, such as interleukin 1 (1). Sub- 
sequently, however, a number of different cell types, including dendritic cells, Lan- 
gerhans cells, B cells, and a variety of cell lines have also been shown to serve as 
stimulator cells (2-5). Thus, the ability to process and present exogenous antigens is 
not a unique property of macrophages and this function can be. performed by a variety 
of other cell types. The only apparent common feature of these different cells is that 
to be stimulatory they must express Ia antigens. This is particularly evident in the 
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recent report by Malissen et al. (6) in which murine fibroblasts transfected with Ia 
genes and expressing Ia antigens could present soluble protein antigen to T cells. It 
would thus seem that the ability to process and present exogenous antigens is a common 
feature of lymphoid and nonlymphoid cell types, providing that Ia antigen is expressed. 
One implication of these findings is that Ia is somehow involved in the processing 
mechanism itself, or simply binds small antigenic peptides resulting from a ubiquitous 
cellular catabolic process (7, 8). Thus, some of the major questions remaining to be 
resolved concerning stimulator cells are: (1) Can all Ia-positive cell types from diverse 
sources present all antigens, or do some cell types present only particular types of 
antigens? (2) What is the nature of the association between exogenous antigens and 
Ia, and how do T-cell receptors interact with these determinants? In this report these 
two questions were addressed using T-cell hybridomas reactive to stimulator cells that 
had been chemically conjugated with the antigen N-hydroxysuccinimidy14-azidoben- 
zoate (HSAB).3 It was found that not all la-positive celI types were stimulatory following 
HSAB conjugation, suggesting that there may be diversity in stimulator cell require- 
ments. In addition, it is also shown that the relevant antigen in this system is a non- 
Ia membrane structure coupled with HSAB, and that Ia and antigen can be indepen- 
dently modulated. The utility of this system is that the HSAB antigen is photoreactive, 
and exposure of HSAB-coupled cells specifically eliminates T-cell recognition. This 
experimental approach should allow definition of the cellular components involved 
in T-cell antigen recognition through selective crosslinking of those structures in prox- 
imity to the antigen. 
MATERIALS AND METHODS 
Animals. All mice and rats used in these experiments were bred and maintained in 
the animal facility at the University of Michigan Medical School. 
T-Cell hybridomas. Bab. 14 (H-2d) mice were immunized in the footpads with 50 
~1 of 50 pg of HSAB (Pierce Chemical Co., Rockford, Ill.) emulsified in Complete 
Freunds Adjuvant (CFA, Difco Laboratories, Detroit, Mich.), or with CFA alone, and 
the popliteal lymph nodes removed 2 weeks later. Lymph node cells from CFA-immune 
mice were cultured with 50 &ml of PPD (Connaught Medical Research Labs, Ontario, 
Canada) and those from HSAB-immune mice treated with HSAB as follows. HSAB 
at 10 mg/ml in dimethyl sulfoxide (DMSO, Sigma Chemical Co., St. Louis, MO.) was 
rapidly diluted in 5 ml of Hank’s balanced salt solution (HBSS, KC Biological, Lenexa, 
Kans.) with vigorous vortexing to 2.5 pg/ml final concentration and added to the 
HSAB-immune lymph node cells. After 60 min incubation at 37°C the cells were 
washed in HBSS to remove unconjugated HSAB. Both PPD- and HSAB-immune 
lymph node cells were cultured at 2.5 X 106/ml in RPM1 1640 medium (M.A. Bio- 
products, Walkersville, Md.) containing 300 pg/ml glutamine (KC Biological), 100 
units/ml penicillin-streptomycin (KC Biological), 5 X lop5 A4 2-mercaptoethanol 
(Bio-Rad Laboratories, Richmond, Calif.), and 10% heat-inactivated fetal calf serum 
(FCS, HyClone Laboratories, Logan, Utah) for 3 days and the blast cells harvested by 
centrifugation on Ficoll-Hypaque (Sigma Chemical Co.). The blasts were cultured 
3 Abbreviations used: ~YMM, wmethylmannoside; ANB-NOS, N-5-azido-2-nitrobenzoyloxy succinimide; 
CAS, supematant tluid from Con A-stimulated spleen cek, FCS, fetal calf serum; HSAB, N-hydroxysuc- 
cinimidyl Cazidobenzoate; IL2, interleukin 2; PBS, phosphate-buffered saline; PPD, purified protein de- 
rivative of tuberculin; Con A, concanavalin A. 
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for an additional 2 days at 1 to 2 X 105/ml in medium containing 25% of supernatant 
fluid from conconavalin A (Con A, Miles-Yeda International, Elkhard, Ind.) stimulated 
rat spleen cells (CAS) and 0.1% cll-methylmannoside (aMM, Sigma). The resulting 
blast cells were fused with BW5147 cells (a generous gift from Dr. Ethan Shevach, 
Laboratory of Immunology, NIH) by established procedures (9, 10). The resulting 
hybridomas were screened with HSAB-conjugated Balb/c spleen cells or with untreated 
Balb/c spleen cells and 50 &ml of PPD for IL-2 production as described below. Those 
hybrids that showed HSAB or PPD-specific IL-2 production were further subcloned 
by limiting dilution. Both the HSAB-specific (5DlO. lB8) and PPD-specific (8B2) T 
hybridomas showed genetic restrictions for Iad. All T-cell hybridomas were maintained 
in Dulbecco’s modified Eagle medium (M.A. Bioproducts) containing glutamine, pen- 
icillin-streptomycin, 2-mercaptoethanol, 10% nutrient cocktail (1 l), hypoxanthine, 
aminopterin, thymidine, and 15% heat-inactivated FCS. 
Stimulator cell treatment. The various stimulator cells used in all ofthese experiments 
were Balb/c spleen cells, the Iad-positive B-cell lines A20.2JAd (a generous gift from 
Dr. Phillipa Marrack, National Jewish Hospital, Denver, Colo.), and LB 27.4 (obtained 
from Dr. David Shapiro, The University of Michigan Medical School), and the mac- 
rophage-like cell line P388Dr (from Dr. P. Marrack). The P388D1 were induced to 
express Iad antigens as described before (12) by culture for 1 or 2 days in 25% CAS 
and aMM. The Ia content of these cells was determined by incubating 1 X lo6 cells 
with 25X of supematant fluid containing monoclonal antibody 17/227 [&a. 15 (a gift 
from Dr. John Niederhuber, The University of Michigan Medical School)] for 1 hr 
at 4’C. Following washing in PBS containing 0.02% sodium azide the cells were in- 
cubated for 1 hr at 4°C with 50X PBS azide containing 50,000 cpm of ‘251-protein A 
(a gift from Dr. Rod Naim, The University of Michigan Medical School). The cells 
were washed to remove unbound ‘251-protein A and the cpm determined in a gamma 
counter. Uninduced P388D, showed some Ia expression by this assay, which was 
increased 5- to IO-fold after induction with CAS for 1 or 2 days, respectively. Cultured 
CAS-induced Ia-positive P388Dr for a day in medium without CAS (rested) resulted 
in a 60% reduction in Ia expression, which was reduced to background levels by 2 
days. Operationally, for the purpose of this report, 1 or 2 day CAS-induced P388D1 
will be referred to as Ia positive, while uninduced or induced and rested P388Dr cells 
are referred to as functionally Ia negative. 
For glutaraldehyde fixation, Ia-positive P388D, cells were washed in phosphate- 
buffered saline (PBS, pH 7.2) and treated by mixing for 15 set with 0.025, 0.05, or 
0.1% glutaraldehyde (Sigma Chemical Co.) in PBS. The reaction was terminated by 
addition of excess PBS containing 0.1% glycine (Sigma Chemical Co.) and the cells 
washed 3X in HBSS prior to use as stimulator cells. All stimulator cells were treated 
with either HBSS alone (untreated controls) or with HBSS containing HSAB (20 or 
40 pg/rnl in most experiments) as described above and washed to remove unbound 
HSAB before addition to culture with T cells. 
In some experiments, unconjugated or HSAB-conjugated Ia+ P388D, cells in PBS 
or HBSS were exposed in uncovered tubes or dishes for 15 set to a broad spectrum 
uv light to photoactivate the HSAB. As a control, the HSAB solution was exposed to 
uv light for 60 set prior to addition to the Ia+ P388D1 cells. In experiments to determine 
the cellular structures HSAB is conjugated to, Ia+ or Ia- P388D, cells were coupled 
with 50 to 250 &i ‘H-HSAB (50 Ci/mmol, New England Nuclear, Boston, Mass.) as 
described above. The cells were left unlit or exposed to uv light, then solubilized 
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in 0.5% Nonidet-P40, and the cell lysates examined for HSAB-coupled proteins 
and immunoprecipitation with anti-Ia. 15 monoclonal antibody and analyzed by 
SDS-PAGE. 
Assay of interleukin 2 (IL-2). The HSAB or PPD-specific T-cell hybridomas (1 to 
2 X 105/well) were cultured with 1 X lo5 untreated or HSAB-treated stimulator cell 
lines, or 1 X lo6 spleen cells, in hybridoma maintenance medium. In experiments 
with the PPD-specific hybridoma, no antigen or 10 &well of soluble PPD was added 
to cultures with untreated stimulators. After 24 hr of culture the supematant fluid was 
removed and assayed for IL-2 with IL-2-dependent HT-2 cells (a generous gift from 
Dr. Ethan Shevach) as described elsewhere (9,lO). The greatest dilution of supematant 
fluid maintaining’>90% HT-2 viability was the endpoint scored and the results ex- 
pressed as IL-2 units/ml (12). 
RESULTS 
Stimulator Cell Requirement of HSAB-SpeciJic T-Cell Hybridomas 
The purpose in initiating these studies was to develop a system in which antigen 
could be coupled to the T-cell receptor and/or Ia antigens during the specific interaction. 
One way to accomplish this was to produce T-cell hybridomas directed against a 
photoactivatable antigen that could be induced to covalently couple to the T-cell 
receptor or Ia antigens during the cellular interactions with the APC. Accordingly, we 
produced T-cell hybridomas against HSAB-coupled APC. Although the HSAB-coupled 
self protein that provides the antigen determinant is not readily identified, it was 
reasoned that it is entirely unknown what happens to peptide and protein antigens 
upon processing, and to what self proteins these may become coupled. That is, in any 
antigen system, the final form of the antigen recognized by T cells is completely un- 
known. Thus, the use of HSAB-coupled cells is no less defined than adding HSAB- 
conjugated peptides or proteins and HSAB-coupled cells offer the advantage that the 
specificity is likely to involve the HSAB molecule itself. The important criteria were 
that the T-cell response be genetically restricted by Ia antigens, and that the T cells 
are specific for HSAB, and not some conformational change caused by conjugation. 
Accordingly, the genetic restrictions were determined by using HSAB-coupled spleen 
cells from genetically different mice as shown in Table 1. Results of this analysis 
indicate that the HSAB-specific response is most likely genetically restricted by the K 
or I-Ad antigens. The ability of the response to be partially blocked with anti-I-Ad 
monoclonal antibodies (data not shown) and the failure of Kd expressing cells to 
stimulate indicates that the response is genetically restricted by I-Ad. The fine specificity 
of the response was determined by comparing the ability of HSAB and ANB-NOS to 
stimulate the HSAB-specific T cells. ANB-NOS differs from HSAB solely by inclusion 
of a NO* on the benzene ring, but couples identically to Lys in proteins through the 
reactive succinimide. Thus, if T cells were reacting only to protein conformation 
caused by conjugation, they would likely respond the same to HSAB and ANB-NOS. 
As shown in Table 2, the HSAB-specific T hybridoma cells responded only to HSAB 
and not ANB-NOS coupled spleen cells. This observation strongly suggests that the 
specificity of the HSAB response is directed in part against the benzene ring .of the 
HSAB molecule, which also contains the azido group capable of forming covalent 
bends with adjacent structures upon exposure to light. 
The next important task was to find a cell line capable of stimulating the HSAB- 
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TABLE 1 





















’ Spleen cells from the mouse strains indicated were conjugated with HSAB (10 pg/ml), or left untreated, 
then cultured overnight with HSAB-specific T hybridoma cells and the IL2 contained in the culture su- 
pernatant fluid was assessed as described under Materials and Methods. All cultures with unconjugated 
spleen cells contained ~20 IL-2 units/ml. 
specific T-hybridoma cells to provide a homogeneous source of APC. Initial experi- 
ments were therefore performed to determine if Ia-positive continuous cell lines could 
replace spleen cells as stimulator cells when directly conjugated with HSAB. To our 
surprise, it was found that HSAB-conjugated Ia-positive B-cell lines, A20.2JAD and 
LB.27.4, failed to stimulate IL-2 release by HSAB-specific T hybrids (Table 3). This 
lack of stimulatory activity did not reflect an inherent cellular defect since both B-cell 
lines presented PPD efficiently to a PPD-specific T hybridoma. In similar fashion 
P388D, cells, a macrophage-like cell line, also failed to stimulate an HSAB-specific 
response. However, induction of Ia expression by culture of P388D, cells with CAS 
resulted in excellent T-cell stimulation following HSAB conjugation. 
The failure of Ia-positive B-cell lines to stimulate HSAB responses could be due to 
several reasons: (1) B cells cannot process HSAB appropriately even following direct 
TABLE 2 
Specificity of the Anti-HSAB T-Cell Hybridoma Response 
Spleen cell treatment0 IL2 units/ml 
0 <lO 
HSAB 
20 &ml 80 
10 &ml 80 
5 at/ml 80 
ANB-NOS 
20 &ml <IO 
10 &ml <IO 
5 fig/ml 110 
’ BaIb/c spleen cells were treated with HSAB or ANB-NOS at the indicated concentrations, then added 
to HSABspecific T hybridomas and IL2 production was measured as described under Materials and Methods. 
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TABLE 3 
The Ability of Various Cell Lines to Stimulate HSAB- or PPD-Specific T-Cell Hybridomas 
IL2 units/ml 
T-cell hybridoma specificity 
Stimulator cell” Antigen HSAB PPD 
Balb/c spleen - t20 <20 
+ 80 640 
A20-2JAd - <20 <20 
+ 120 >640 
LB.27.4 <20 <20 
+ <20 ,640 
Ia- P388Di <20 NDb 
+ <20 
Ia+ P388Di <20 <20 
+ 160 320 
’ The indicated stimulator cells were either untreated, or HSAB treated for culture with HSAB-specific T 
hybridomas, or untreated and cultured with or without 10 &well of PPD with the PPD-specific T-cell 
hybridomas as described under Materials and Methods. P388Di cells were induced for la expression (Ia’) 
by culture for a day in CAS. Units/ml of IL-2 contained in the supematant fluids of each culture were 
determined as described under Materials and Methods. 
b Not determined. 
chemical coupling of HSAB to the cell surface; (2) this HSAB-specific T-cell hybrid 
requires cofactors for IL-2 release that are provided by macrophages but not B cells; 
or (3) the B-cell lines lack a surface structure that is present on P388Di that becomes 
conjugated with HSAB and provides the relevant antigen. To discriminate between 
these possibilities, Ia-positive P388Di cells were fixed with glutaraldehyde prior to 
HSAB coupling and examined for their stimulator-y capacity. As shown in Table 4, 
Ia-positive P388Di cells fixed with up to 0.1% glutaraldehyde then HSAB conjugated 
efficiently stimulated HSAB-specific T hybrids. The effectiveness of glutaraldehyde 
TABLE 4 




T-cell hybridoma specificity 
HSAB PPD 
0 640 10,240 
0.025 640 40 
0.05 640 <20 
0.1 320 c20 
’ P388Dr cells cultured for 2 days with CAS (Ia-positive) were treated with 0, 0.025%, 0.05%. or 0.1% 
glutaraldehyde then conjugated with 40 &ml of HSAB or added to culture with 10 &well of PPD for 
stimulation of HSAB- or PPD-specific T hybridomas, respectively. IL2 activity contained in the culture 
supematant fluids was determined as described under Materials and Methods. IL2 activity in cultures 
without antigen was ~20 units/ml for both T hybrids. 
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fixation was shown by the failure of the fixed cells to process and present PPD, as has 
been shown with other peptide antigens (13). These results suggest that the inability 
of HSAB-conjugated B-cell lines is not due to released cofactors (although surface- 
bound cofactors cannot be excluded), and that HSAB processing is not required for 
antigen presentation. Therefore, the more likely explanation for the inability of HSAB- 
conjugated B-cell lines to stimulate is that they lack a particular surface structure 
expressed by la-positive P388Dr cells that is either coupled with HSAB to provide the 
relevant antigen or is otherwise important in recognition. However, since these B-cell 
lines express Ia, the structure to which HSAB couples is most likely not Ia. 
Modulation of Ia on the Stimulatory Capacity of HSAB-Conjugated P388D1 Cells 
The experiments described above suggest that the antigen recognized by the HSAB- 
specific hybridoma is not simply Ia antigens coupled with HSAB. To investigate this 
in a more rigorous fashion, functionally Ia-negative P388Di cells were conjugated 
with HSAB then incubated with CAS to induce Ia expression to determine if the 
relevant structure to which HSAB coupled was expressed in the absence of Ia. As 
shown in Table 5, HSAB-conjugated la-negative P388Dr cells that were subsequently 
induced to express Ia stimulated HSAB T-cell hybrid responses as well as direct HSAB 
conjugation of Ia-positive P388Dr cells. These results clearly indicate that the relevant 
antigen is not HSAB-coupled Ia and that the responsible surface structure is expressed 
independently of Ia. 
One of the interesting possibilities raised by this experiment is that Ia and the HSAB- 
coupled surface structure may not be tightly physically linked and can be independently 
modulated. As noted in the above experiment (Table 5, Group 2), Ia-positive P388D, 
cells that are cultured for a day in the absence of CAS become functionally Ia negative 
and fail to stimulate HSAB responses. Taking advantage of this observation, it was 
possible to modulate Ia antigen expression to determine if Ia physically combined 
TABLE 5 
Stimulatory Capacity of HSAB-Conjugated Ia-Negative P388Di Cells upon 
Subsequent Induction of Ia Expression 
Day 0” treatment 
Culture 1 day Day 1 antigen 
with CAS treatment IL-2 units/ml 





4;;: ;;g: HSAB >320 Group 2 la+ P388Di HSAB <20 
HSAB treltedd 11’ ::,“z: 
None >320 
Group 3 Ia- P388D 
None 120 
a Ia-negative P388Di that were untreated (Group 1) or HSAB conjugated (Group 3), or 1 day CAS- 
induced Ia-positive P388Di (Group 2), were cultured for a day in the presence (+) or absence (-) of CAS 
and nMM. The washed cells were either left untreated or treated with 40 &ml of HSAB as indicated then 
cultured for a day with HSAB T hybrids. The IL-2 units/ml contained in each culture supematant were 
determined as described under Materials and Methods. 
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with the HSAB-coupled structure and removed this structure when la was lost from 
the cell. Accordingly, Ia-negative or la-positive P388Di were conjugated with HSAB, 
then incubated in the presence or absence of CAS for a day; then each of these groups 
was cultured for an additional day with or without CAS. At each time all groups were 
tested for their ability to stimulate HSAB-specific T hybrids without additional HSAB 
treatment. As shown in Table 6, HSAB-conjugated Ia-positive P388Di lost their ability 
to stimulate when Ia was lost, but regained their stimulatory capacity when Ia was 
subsequently reexpressed. Thus, antigen is not removed from the cell concomitant 
with the loss of Ia, but remains such that the cell can again stimulate when Ia is 
reexpressed. In reciprocal fashion, HSAB-conjugated Ia-negative P388Di can be mod- 
ulated to express and lose Ia and retain the relevant antigen to present whenever Ia is 
present. These experiments show that Ia and antigen can be separately modulated. 
A number of other biochemical experiments were performed to determine if HSAB 
was either directly conjugated to Ia, or was close enough to Ia to be crosslinked when 
exposed to uv light. Unfortunately, all of these results were negative (data not shown) 
and anti-Ia antibody failed to immunoprecipitate any 3H-HSAB associated with Ia 
from coupled Ia-positive P388Di that were either unlit or exposed to uv light. These 
results are consistent with the functional results described above indicating that the 
HSAB is not coupled to Ia. Of interest, 3H-HSAB couples to 17 to 22 discrete cellular 
structures on Ia-positive or la-negative P388Di cells (the pattern is identical for both) 
of molecular weights of between 40 and 100K. Upon exposure to light, this pattern 
TABLE 6 
Effect of Gain and Loss of Ia Antigens on the Stimulatory Capacity of HSABConjugated P388Di Cells 
Day 0” treatment 
Culture 
Day 0 Culture day 1 Day 1 day 2 with Day 2 
IL-2 units/ml with CAS IL-2 units/ml CAS IL-2 units/ml 
None <20 
Ia- P388Di <20 - 




Ia+ P388Di <20 - 
HSAB Ia- P388Di 
160 
Ia+ P388Di 
a The design of this experiment is similar to that described in the legend for Table 5. Ia-negative or 1 day 
CAS-induced Ia-positive P388Di cells were left untreated or treated with 40 &ml HSAB on Day 0. The 
HSAB-conjugated cells were then cultured for a day (Day 1) with or without CA!?, then each of these groups 
cultured for an additional day (Day 2) with or without CAS as indicated. It should be noted that cells were 
never exposed to HSAB after initial conjugation on Day 0. Aliquots of cells from each stimulator treatment 
group on Days 0, 1, or 2 were tested for stimulatory activity by culture for a day with HSABspecific T- 
hybridoma cells. IL2 units/ml for each group on the day indicated were determined as described under 
Materials and Methods. 
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of bands is unaltered and no higher mol wt aggregates are formed by HSAB crosslinking. 
This is not surprising since HSAB is a small molecule and would only crosslink struc- 
tures that are very closely associated (within around 6 A) on the membrane. It would 
therefore be expected that upon exposure to uv, HSAB under these conditions would 
crosslink mainly, if not entirely, to the structure to which it is chemically coupled. 
This is an important point to consider when interpreting the experiments de- 
scribed below. 
SpeciYc Photoelimination of the HSAB Antigenic Determinant 
Since the primary feature of the HSAB system is to provide a photoactivatable 
antigen, it was important to determine what effect light had on the HSAB-antigenic 
determinant. In initial experiments, HSAB-coupled Ia-positive P388Di cells were briefly 
exposed to light to activate the HSAB and determine if this altered antigenicity. As 
shown in Table 7, lighting of HSAB-coupled cells eliminated their stimulatory capacity. 
This effect was seemingly specific since exposure of Ia-positive P388Di cells to light 
prior to HSAB conjugation had no effect on their stimulatory capacity. Of interest is 
the observation that lighting HSAB prior to incubation with Ia-positive P388D, cells 
likewise has no effect on stimulation. This suggests that the HSAB-specific T cells are 
not highly specific for the azido group, and that elimination of antigenicity by lighting 
is not due to direct effects on HSAB, but rather results from some crosslinking reaction. 
However, it could not be determined if lighting of HSAB-coupled Ia-positive P388D, 
cells was a nonspecific result of HSAB crosslinking on that cell. To examine this, 
HSAB-coupled Ia-positive P388D1 were exposed to light and added to culture with 
PPD and PPD-specific T-hybridoma cells. If crosslinking by HSAB was nonspecifically 
inhibitory, then the cells would be unable to stimulate a PPD-specific response. As 
shown in Table 8, lighting of HSAB-coupled Ia-positive P388Di cells dramatically 
inhibited the stimulation of the HSAB-specific response, but had no effect on stimu- 
lation of the PPD-specific response. This result indicates that the effects of uv light 
selectively eliminate only the HSAB antigen on the surface of the APC and do not 
interfere with their stimulatory capacity. In other experiments (data not shown) culture 
of HSAB-coupled APC for 0 to 18 hr after conjugation (to allow any new molecular 
associations to occur) then exposing them to light, or not, showed that the HSAB- 
antigenic determinant was photosensitive at all time points tested. Thus, new asso- 
ciations with HSAB-coupled membrane structures, if they occur, does not change the 
TABLE 7 
Elimination of T-Cell Stimulation by Lighting HSAB-Conjugated Antigen-Presenting Cells 
Antigen-presenting cell treatment’ IL-2 units/ml 
Group 1 Ia+ P388Di - HSAB >640 
Group 2 Ia+ P388Di - HSAB - Lit <20 
Group 3 Lit Ia+ P388d, - HSAB >640 
Group 4 Ia’ P388Di - Lit HSAB >640 
’ Unlit or lit (Group 3) Ia+ P388Di were conjugated with the photoactivatable antigen HSAB, either unlit 
or lit (Group 4), and the HSAB-coupled cells were left unlit or exposed to light (lit, Group 2) and added to 
culture with HSAB-specific T-cell hybridomas as described under Materials and Methods. 
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TABLE 8 
Specificity of Lighting on Elimination of Antigenicity by the Photoactivatable HSAB Antigen 
IL-2 units/ml by T-cell 
hybridomas directed 
against 
Antigen-presenting cell treatment” HSAB PPD 
Group I Ia+ P388Di 
Group 2 Ia’ P388Di - HSAB 
Group 3 Ia+ P388Di - PPD 
Group 4 Ia+ P388Di - HSAB - PPD 






’ Untreated or HSAB-conjugated (10 r/ml) Ia+ P388Di cells were cultured with or without soluble PPD 
(10 fig) and HSAB-specific or PPD-specific T-cell hybridoma cells. In Group 5 the HSAB-coupled cells were 
exposed to light before the addition of PPD and T cells. 
b Not determined. 
ability of light to inactivate the HSAB determinant, presumably by crosslinking. As 
discussed above, this crosslinking of HSAB with light is most likely with the same 
structure to which it is chemically coupled. 
DISCUSSION 
The purpose of this report is to describe a T-cell antigen-presenting cell system 
utilizing a photoactivatable crosslinking antigen to help identify the antigen-specific 
recognition complex. Several interesting findings were observed that are of importance 
to understanding antigen presentation. The first observation is that HSAB-coupled Ia 
does not seem to provide the antigenic determinant recognized by the HSAB-specific 
T cells. This was demonstrated in several ways. The first is that Ia-positive B-cell lines, 
which present a variety of antigens (4, 13) fail to stimulate HSAB T hybrids even 
when HSAB is chemically coupled to their surface. If HSAB-conjugated Ia provided 
the relevant antigen, then these Ia-positive cells would have been efficient stimulators. 
The second is that HSAB coupled Ia-negative P388Di cells are efficient stimulators if 
Ia expression is induced at a later time. In this instance it is clear that the antigenically 
relevant surface structure is present prior to Ia expression and is not provided by direct 
conjugation to Ia. Moreover, glutaraldehyde fixed Ia-positive P388Dr treated with 
HSAB are efficient stimulators ruling out the necessity for HSAB antigen processing 
or a cofactor requirement for stimulation of the HSAB T hybrids. Third, immuno- 
precipitation of 3H-HSAB-coupled Ia-positive P388Dr cell lysates with anti-Ia mono- 
clonal antibodies failed to demonstrate any Ia-associated antigen. Taken together, 
these results indicate that the relevant antigen recognized by these T cells consists of 
HSAB coupled to some non-Ia surface structure present on P388Di macrophage-like 
cells. This is of interest since other recent studies (14) have suggested that exogenous 
antigen is intimately associated with cellular Ia antigens. In addition, in other systems 
employing TNP conjugation of stimulator or target cells it was suggested that directly 
TNP modified MHC antigens provided the relevant antigen recognized by T cells 
(15,16). However, little direct TNP mod&&on of MHC antigens was found following 
ANTIGEN PRESENTATION TO T CELLS 361 
conjugation to guinea pig macrophages and it was speculated that the relevant T-cell 
antigen in this case was TNP coupled to another membrane constituent (17). In this 
system it was also found that TNP coupled glutaraldehyde-fixed macrophages were 
efficient stimulators ruling out the necessity for antigen processing (18), as reported 
here for HSAB. 
The observation that HSAB-specific T hybridomas are stimulated only by the Ia- 
positive macrophage-like cell line and not by the la-positive B-cell lines is also of 
interest. One explanation for this may be that the Ia expressed by both cell types is 
slightly different, either in primary sequence or in modifications such as glycosylation 
(19), and that the T cells are specific for a particular form of Ia. This does not seem 
likely, though, since many T-cell hybridomas restricted to I-Ad are stimulated by both 
A20 and Ia-positive P388D1 cells, as shown here with the PPD-specific hybrids. Another 
possibility is that the B-cell lines lack the relevant surface structure expressed by mac- 
rophages that is coupled by HSAB to provide the T-cell antigen. This is a distinct 
possibility, although SDS-PAGE analysis of the surface structures coupled with 3H- 
HSAB on A20 and P388D1 cells showed no apparent differences. A third possibility 
is that this T-cell hybrid may require another macrophage structure for activation that 
is absent from B cells and for this reason is “macrophage-specific.” 
Another unique feature of the antigen system examined here is the photosensitivity 
of the HSAB antigenic determinant. Thus, at any time after HSAB coupling, exposure 
of the APC to light selectively and specifically eliminates their ability to stimulate the 
HSAB-specific T-cell hybridomas. Since the T cells show specificity for the benzene 
ring of the molecule, the most likely explanation for this is that light causes HSAB to 
covalently crosslink to some APC surface and thereby obscure the determinant bound 
by the antigen-specific T-cell receptor. If this is the case, then the photoreactive end 
of the chemically coupled HSAB must be very close to structures it can crosslink to. 
Since SDS-PAGE analysis showed that lighting of 3H-HSAB-coupled cells caused no 
detectable aggregation, nor any associations with Ia, the most likely explanation is 
that upon lighting HSAB crosslinked with the same structure to which it was already 
chemically bound. This seems most likely given the small size of the HSAB molecule 
allowing crosslinking of only structures that are extremely close to the HSAB. Thus, 
crosslinking of the structure by HSAB causes the antigenic determinant to be “locked 
in” such that it cannot be bound by the T-cell receptor. The implication of this is that 
the T-cell receptor must physically contact the HSAB molecule. Thus, this system 
may provide an excellent opportunity to directly crosslink the HSAB-coupled APC 
structures and the T-cell receptor to directly determine the cellular structures involved 
in specific interactions with antigen. 
If the T cells recognize the HSAB antigen in association with Ia, it must involve a 
mechanism to bring these two elements together. There are several ways by which this 
might occur. The first would be a variation of the determinant selection model in 
which antigen (HSAB coupled non-MHC membrane proteins) is bound to Ia and that 
this complex is recognized by the T-cell receptor (7, 8). Alternatively, Ia and the 
antigenically relevant membrane structure may be only loosely organized in proximity 
in the membrane without any particular additional interaction caused by HSAB con- 
jugation. The T cell would then cause the Ia and HSAB antigen to become physically 
associated for recognition as a single determinant by the T receptor (The Induced Fit 
Hypothesis, 20). Alternatively, recognition of the HSAB antigen and Ia may be unique 
events. These mechanisms will be tested in the future by photocrosslinking the HSAB 
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antigen to the structures with which it interacts during the antigen-specific T-cell- 
APC cell interactions. This should allow determination if antigen associates with Ia 
only in the presence of T cells, or if T-cell receptor binding of antigen is distinct from 
recognition of Ia. 
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